Biotech · Private company
Op-T LLC
Track this companyFree. Adds Op-T LLC to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- OPT101Phase 2 · Type I DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- OPT101Phase 1 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- OPT101Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- OPT101Phase 1 · SepsisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes MellitusPHASE2 · RECRUITING · started Apr 10, 2026ClinicalTrials.gov NCT06964087 · fetched Nov 12, 2026
- OPT101 in Patients With Community Acquired Pneumonia (CAP) With SepsisPHASE1 · NOT_YET_RECRUITING · started Dec 1, 2025ClinicalTrials.gov NCT06669403 · fetched Nov 12, 2026
- OPT101 in Type 1 Diabetes PatientsPHASE1 · COMPLETED · started Sep 27, 2022ClinicalTrials.gov NCT05428943 · fetched Nov 12, 2026
- 1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.PHASE1 · COMPLETED · started Feb 18, 2021ClinicalTrials.gov NCT04589403 · fetched Nov 12, 2026